TY - JOUR
T1 - Effect of excessive coffee consumption on the clinical course of a patient with bipolar disorder
T2 - A case report and literature review
AU - Kunitake, Yutaka
AU - Mizoguchi, Yoshito
AU - Sogawa, Rintaro
AU - Matsushima, Jun
AU - Kato, Takahiro A.
AU - Kawashima, Toshiro
AU - Monji, Akira
N1 - Publisher Copyright:
© Wolters Kluwer Health, Inc. All rights reserved.
PY - 2017/7/1
Y1 - 2017/7/1
N2 - Objective The aim of this study was to examine the impact of excessive caffeine consumption on therapeutic outcomes in bipolar disorder. Methods and Results We report on a case of a patient with bipolar disorder whose psychiatric symptoms were ameliorated with the elevation of lithium concentrations after the reduction of excessive daily coffee consumption, and we review the relevant literatures. Conclusions Excessive coffee consumption may exacerbate the therapeutic course of bipolar disorder through its effects on the mechanisms underlying bipolar disorder itself, as well as by affecting the blood concentration of lithium.
AB - Objective The aim of this study was to examine the impact of excessive caffeine consumption on therapeutic outcomes in bipolar disorder. Methods and Results We report on a case of a patient with bipolar disorder whose psychiatric symptoms were ameliorated with the elevation of lithium concentrations after the reduction of excessive daily coffee consumption, and we review the relevant literatures. Conclusions Excessive coffee consumption may exacerbate the therapeutic course of bipolar disorder through its effects on the mechanisms underlying bipolar disorder itself, as well as by affecting the blood concentration of lithium.
UR - http://www.scopus.com/inward/record.url?scp=85020554291&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85020554291&partnerID=8YFLogxK
U2 - 10.1097/WNF.0000000000000222
DO - 10.1097/WNF.0000000000000222
M3 - Review article
C2 - 28622205
AN - SCOPUS:85020554291
SN - 0362-5664
VL - 40
SP - 160
EP - 162
JO - Clinical Neuropharmacology
JF - Clinical Neuropharmacology
IS - 4
ER -